Zimmer Total Other Income Expense Net from 2010 to 2026
| ZBH Stock | USD 86.18 0.04 0.05% |
Total Other Income Expense Net | First Reported 2000-03-31 | Previous Quarter -75.4 M | Current Value -72.1 M | Quarterly Volatility 39.4 M |
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 B, Interest Expense of 145.4 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 4.48, Dividend Yield of 0.0153 or PTB Ratio of 1.88. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
Zimmer | Total Other Income Expense Net | Build AI portfolio with Zimmer Stock |
The Total Other Income Expense Net trend for Zimmer Biomet Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Zimmer Biomet is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Zimmer Biomet's Total Other Income Expense Net Growth Pattern
Below is the plot of the Total Other Income Expense Net of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
| Total Other Income Expense Net | 10 Years Trend |
|
Total Other Income Expense Net |
| Timeline |
Zimmer Total Other Income Expense Net Regression Statistics
| Arithmetic Mean | (214,192,382) | |
| Coefficient Of Variation | (56.14) | |
| Mean Deviation | 94,889,242 | |
| Median | (224,190,000) | |
| Standard Deviation | 120,247,307 | |
| Sample Variance | 14459.4T | |
| Range | 414.1M | |
| R-Value | (0.52) | |
| Mean Square Error | 11314.4T | |
| R-Squared | 0.27 | |
| Significance | 0.03 | |
| Slope | (12,290,868) | |
| Total Sum of Squares | 231350.6T |
Zimmer Total Other Income Expense Net History
About Zimmer Biomet Financial Statements
Investors use fundamental indicators, such as Zimmer Biomet's Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Other Income Expense Net | -224.2 M | -213 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Zimmer Biomet Correlation against competitors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is there potential for Health Care Equipment & Supplies market expansion? Will Zimmer introduce new products? Factors like these will boost the valuation of Zimmer Biomet. Anticipated expansion of Zimmer directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 0.96 | Earnings Share 4.03 | Revenue Per Share | Quarterly Revenue Growth 0.097 |
Zimmer Biomet Holdings's market price often diverges from its book value, the accounting figure shown on Zimmer's balance sheet. Smart investors calculate Zimmer Biomet's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Zimmer Biomet's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.